Products Categories
CAS No.: | 17590-01-1 |
---|---|
Name: | AMFETAMINIL |
Article Data: | 5 |
Molecular Structure: | |
Formula: | C17H18N2 |
Molecular Weight: | 250.343 |
Synonyms: | Acetonitrile,[(a-methylphenethyl)amino]phenyl-(8CI);Glycinonitrile, N-(a-methylphenethyl)-2-phenyl- (7CI);AN 1 (pharmaceutical);Amfetaminil;Amphetaminil;Aponeuron;N-(b-Phenylisopropyl)-a-aminophenylacetonitrile;NSC 67172;a-Phenyl-a-N-(1-phenylisopropyl)aminoacetonitrile;a-Phenyl-a-[N-(b-phenylisopropyl)amino]acetonitrile; |
EINECS: | 241-560-8 |
Density: | 1.062 g/cm3 |
Melting Point: | 81-85 °C |
Boiling Point: | 405.167 °C at 760 mmHg |
Flash Point: | 198.838 °C |
Appearance: | White to Off-White Solid |
PSA: | 35.82000 |
LogP: | 3.86298 |
The Amfetaminil, with the CAS registry number 17590-01-1, is also known as ((alpha-Methylphenethyl)amino)phenylacetonitrile. It belongs to the product categories of Amines; Aromatics; Intermediates & Fine Chemicals; Pharmaceuticals. Its EINECS number is 241-560-8. This chemical's molecular formula is C17H18N2 and molecular weight is 250.34. What's more, its systematic name is Phenyl[(1-phenyl-2-propanyl)amino]acetonitrile.
Physical properties of Amfetaminil are: (1)ACD/LogP: 3.782; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.78; (4)ACD/LogD (pH 7.4): 3.78; (5)ACD/BCF (pH 5.5): 437.55; (6)ACD/BCF (pH 7.4): 441.01; (7)ACD/KOC (pH 5.5): 2698.18; (8)ACD/KOC (pH 7.4): 2719.49; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 35.82 Å2; (13)Index of Refraction: 1.573; (14)Molar Refractivity: 77.658 cm3; (15)Molar Volume: 235.797 cm3; (16)Polarizability: 30.786×10-24cm3; (17)Surface Tension: 44.1 dyne/cm; (18)Density: 1.062 g/cm3; (19)Flash Point: 198.838 °C; (20)Enthalpy of Vaporization: 65.672 kJ/mol; (21)Boiling Point: 405.167 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: N#CC(NC(C)Cc1ccccc1)c2ccccc2
(2)Std. InChI: InChI=1S/C17H18N2/c1-14(12-15-8-4-2-5-9-15)19-17(13-18)16-10-6-3-7-11-16/h2-11,14,17,19H,12H2,1H3
(3)Std. InChIKey: NFHVTCJKAHYEQN-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 491mg/kg (491mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 24, Pg. 823, 1977. |
mouse | LD50 | oral | 182mg/kg (182mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 24, Pg. 823, 1977. |
mouse | LD50 | subcutaneous | 58mg/kg (58mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 335, 1972. | |
rat | LD50 | intraperitoneal | 58800ug/kg (58.8mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 24, Pg. 823, 1977. |
rat | LD50 | oral | 37600ug/kg (37.6mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 24, Pg. 823, 1977. |
rat | LD50 | subcutaneous | 95100ug/kg (95.1mg/kg) | VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 24, Pg. 823, 1977. |